Related Experiment Video
Updated: Aug 8, 2026
Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model
Published on: February 3, 2021
Bacterial interference in chick embryos
Insights
Nonvirulent staphylococci protect chick embryos from lethal infections by virulent strains. This protection involves delayed bacterial growth and toxin production, influenced by bacterial dose and timing.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Staphylococcal infections pose significant threats.
- Understanding protective mechanisms against bacterial pathogens is crucial.
- Chick embryo models offer a platform for studying host-pathogen interactions.
Purpose of the Study:
- To investigate the protective effect of nonvirulent staphylococci against virulent staphylococcal infections in chick embryos.
- To elucidate the mechanisms underlying this protective phenomenon.
Main Methods:
- Intra-allantoic inoculation of chick embryos with nonvirulent staphylococci (protecting strain) followed by challenge with virulent staphylococci.
- Monitoring embryo survival and assessing bacterial growth and toxic substance production in allantoic fluid.
Main Results:
- Nonvirulent staphylococci conferred significant protection against mortality from virulent staphylococci.
- Protection correlated with delayed growth of the challenge strain and reduced toxin production.
- The efficacy of protection was dependent on the bacterial inocula size and the interval between administrations.
Conclusions:
- Nonvirulent staphylococci can induce a protective state against virulent staphylococcal challenge in chick embryos.
- This protection is mediated by interference with pathogen growth and virulence factor expression, not by transferable soluble factors.
Abstract:
Chick embryos infected intra-allantoically with nonvirulent staphylococci are protected from death due to infection with virulent staphylococci. The protection is associated with a delay in growth of the challenge strain and a delay in the production of toxic substances in the allantoic fluid. The protection is influenced by the number of bacteria in the protecting and challenge inocula and by the interval between the administration of the protecting and challenge strains. Protection cannot be transferred by administration of sterile filtrates of allantoic fluid in which the protecting strain has grown.
